SUBSCRIBE AND ENJOY 15% OFF YOUR FIRST ONLINE PURCHASE*

Retatrutide – 30 MG

£399.00

Type: GLP-1 / GIP / Glucagon Triple Receptor Agonist
Form: Lyophilised Peptide Powder (For Research Use Only)
Purity: ≥99% (HPLC Verified)
CAS Number: 2381089-83-2
Molecular Weight: 4514.05 g/mol

Retatrutide – 30MG offers researchers access to one of the most advanced peptides in metabolic science. Acting as a triagonist, it simultaneously activates GLP-1, GIP, and glucagon receptors to produce synergistic effects on weight loss, glucose control, fat metabolism, and energy expenditure.

This 30MG vial is an optimal mid-range dose for researchers running 4–6 week protocols, providing an excellent balance between volume, cost, and flexibility.

Research Applications:

  • Obesity Research:
    Demonstrated >24% average bodyweight reduction in human clinical trials

  • Insulin Sensitivity & Glucose Regulation:
    Enhances insulin secretion and improves glycaemic control in diabetic models

  • Fat Oxidation & Energy Expenditure:
    Promotes lipolysis and thermogenesis, preserving lean mass while targeting fat stores

  • Appetite Suppression:
    Reduces hunger through central nervous system pathways, leading to sustained caloric reduction

Reconstitution Guidelines:

  • Reconstitute with 2–3ml of Bacteriostatic Water for Injection (BWFI)

  • Swirl gently until fully dissolved (do not shake)

  • Store reconstituted solution at 2–8°C

  • Use within 30 days of reconstitution for best stability

Why Choose 30MG Retatrutide?

  • Ideal for full 1-month research protocols

  • Flexible for dose titration studies and combination stacks

  • COA provided; manufactured under strict ISO/GMP standards

  • Trusted by metabolic researchers for its consistent purity and performance

⚠️ Important Notice: This product is intended strictly for laboratory research use only. Not for human consumption, therapeutic use, or veterinary application.